Ryan Specialty Q2 Revenue Hits $916.6M, Adjusted EPS $0.74; $300M Buyback Continues
RYAN sits 68% above its 52-week low of $29.28.
Summary
Ryan Specialty posted Q2 revenue of $916.6M and adjusted EPS of $0.74, beating estimates. The company maintained guidance, continued aggressive buybacks, and launched a restructuring program expected to save $80M annually by 2029.
Key Events · Earnings and Guidance · RYAN
-
Q2 Revenue and Earnings Beat
Total revenue grew 7.2% to $916.6M, with net commissions and fees up 7.4%. Adjusted EPS of $0.74 exceeded consensus, driven by strong organic growth in Underwriting Management.
-
Aggressive Share Repurchases
The company repurchased 9.1M shares for $300.2M in H1 2026, with $300M remaining under the expanded $600M authorization. An additional $42M was repurchased in July.
-
Empower Restructuring Program
A three-year restructuring plan expected to cost $160M through 2028, targeting $80M in annual savings by 2029. Q2 charges were $33.3M, including a $12M software impairment.
-
Option Settlement Agreement
Entered into an agreement with the Ryan Stock Option Trust to repurchase shares upon exercise of incentive options, neutralizing dilution from the 1.79M options granted in May 2026.
Analysis · RYAN · Finance
Ryan Specialty delivered a solid Q2, with revenue up 7.2% to $916.6 million and adjusted EPS of $0.74 beating expectations. The company maintained its full-year guidance while aggressively repurchasing shares — $300 million spent in the first half alone, with another $300 million authorized. The newly launched Empower restructuring program aims to streamline operations and generate $80 million in annual savings by 2029, though it will incur $160 million in one-time costs. The Option Settlement Agreement with the Ryan Stock Option Trust is designed to offset dilution from incentive option grants, keeping share count neutral. These moves signal confidence in the business and a focus on shareholder returns, but the restructuring costs and contingent consideration charges are near-term headwinds.
At the time of this filing, RYAN was trading at $49.25 on NYSE in the Finance sector, with a market capitalization of approximately $11.6B. The 52-week trading range was $29.28 to $61.85. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.